Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009

  title={Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009},
  author={Andrew Jason Cohen and Atonu Rabbani and Nilay D. Shah and G. Caleb Alexander},
  booktitle={Diabetes care},
OBJECTIVE Little is known regarding recent changes in glitazone use. RESEARCH DESIGN AND METHODS Interrupted time series analyses of nationally representative office-visit data using IMS Health's National Disease and Therapeutic Index. RESULTS From 2003 through 2005, glitazone use increased steadily. From February 2005 to January 2007, rosiglitazone use decreased by 16% (95% CI -20 to -11) annually; pioglitazone use increased at an annual rate of 14% (9-18). During a period of Food and Drug… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 8 times over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
24 Extracted Citations
12 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 24 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 12 references

National trends in treatment for type 2 diabetes mellitus, 1994–2007

  • GC Alexander, NL Sehgal, RM Moloney, RS. Stafford
  • Arch Intern Med
  • 2010
1 Excerpt

Overall safety of pioglitazone in high-risk patients with type 2 diabetes

  • J Dormandy, A Van Troostenburg de Bruyn, M. Bhattacharya
  • Drug Saf 2009;32:187–202
  • 2009
1 Excerpt

Prioritizing medications for policy and research initiatives examining off-label prescribing

  • SM Walton, GT Schumock, KV Lee, GC Alexander, D Meltzer, RS. Stafford
  • Pharmacotherapy
  • 2008
2 Excerpts

Similar Papers

Loading similar papers…